This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05884320
Brief Title: Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

First Submitted : May 22, 2023
First Submitted that Met QC Criteria : May 22, 2023
First Posted : June 1, 2023

Last Update Submitted that Met QC Criteria : November 15, 2023
Last Update Posted : November 18, 2023